Showing 1371-1380 of 2050 results for "".
- CNET: Mojo Vision Crams its Contact Lens with AR Display, Processor and Wireless Techhttps://modernod.com/news/cnet-mojo-vision-crams-its-contact-lens-with-ar-display-processor-and-wireless-tech/2479469/On Tuesday, startup Mojo Vision detailed its progress on a tiny AR display it embeds in contact lenses, providing a digital layer of information superimposed on what you see in the real world, according to a CNET
- Alcon to Launch TOTAL30 as the First Monthly Replacement, Water Gradient Contact Lenshttps://modernod.com/news/alcon-to-launch-total30-as-the-first-monthly-replacement-water-gradient-contact-lens/2479449/Alcon announced plans to launch TOTAL30, the first-and-only monthly replacement, water gradient lens. Using Alcon’s proprietary water gradient material first introduced with DAILIES TOTAL1 contact lenses, TOTAL30 delivers a premium wearing experience for reusable contact lens wearers, according t
- CooperVision MiSight 1-Day Contact Lens Approved in Chinahttps://modernod.com/news/coopervision-misight-1-day-contact-lens-approved-in-china/2479445/The Chinese National Medical Products Administration (NMPA) has approved CooperVision MiSight 1 day contact lenses for use within the country following a priority review. The innovative soft contact lenses have now become the first indicated product of any type in China that may slow the progress
- CooperVision Report Shows How ECPs Can Boost Contact Lens Trialhttps://modernod.com/news/coopervision-report-shows-how-ecps-can-boost-contact-lens-trial/2479418/A survey commissioned by CooperVision is shedding new light on the value of providing patients more sustainable contact lens options. Following the establishment of CooperVision’s partnership with Plastic Bank to make its clariti 1 day family the first net plastic neutral contact lenses in the US
- Allegro Announces Positive Results of Vehicle-Controlled Ex-US Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Diseasehttps://modernod.com/news/allegro-announces-positive-results-of-vehicle-controlled-ex-us-phase-2-trial-of-alg-1007-for-the-treatment-of-dry-eye-disease/2479410/Allegro Ophthalmics announced that all primary and secondary endpoints of an ex-US vehicle-controlled study of ALG-1007 topical eye drop in patients with dry eye disease (DED) were met. The results were presented by Eric D. Donnenfeld, MD, at the 2021 American Society of Cataract and Refractive S
- Contact Lens Institute Unveils Nationwide “See Tomorrow Campaign;” Industry Launch Event Slated for July 22https://modernod.com/news/contact-lens-institute-unveils-nationwide-see-tomorrow-campaign-industry-launch-event-slated-for-july-22/2479347/A new professional and consumer initiative from the Contact Lens Institute (CLI) is poised to reveal insights about how patient psyches surrounding vision, health care and their lives have changed over the course of the pandemic—and the ensuing opportunities for the optometry community. The CLI <
- Bausch + Lomb Expands Parameters for Bausch + Lomb Ultra Multifocal for Astigmatism Contact Lenseshttps://modernod.com/news/bausch-lomb-expands-parameters-for-bausch-lomb-ultra-multifocal-for-astigmatism-contact-lenses/2479319/Bausch + Lomb announced the US launch of expanded parameters for Bausch + Lomb ULTRA Multifocal for Astigmatism contact lenses. The expansion, which includes the addition of -2.25D and -2.75D cylinder power parameters, will be part of the company’s standard offering of the lens and will ext
- Why Can’t Americans Buy Contact Lenses From Vending Machines?https://modernod.com/news/why-cant-americans-buy-contact-lenses-from-vending-machines/2479238/A recent report in The Federalist details the ability to purchase contact lenses throughout most of Europe versus the United States, and the role regulatory agencies have in wh
- New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues To Reduce The Risk Of Moderate To Advanced AMD Progressionhttps://modernod.com/news/new-national-eye-institute-data-shows-areds2-nutrient-formula-continues-to-reduce-the-risk-of-moderate-to-advanced-amd-progression/2479193/Bausch + Lomb announced new data from the National Eye Institute (NEI) 10-Year Follow-on Study Results of the Age-Related Eye Disease Study 2 (AREDS2), which reaffirms the clinical outcomes of the AREDS2 study. Based on this data, the NEI continues to recommend a specific nutrient formula to help
- New Alcon Data on Contact Lens, Dry Eye, and Ocular Health to Be Presented at ARVO 2021https://modernod.com/news/new-alcon-data-on-contact-lens-dry-eye-and-ocular-health-to-be-presented-at-arvo-2021/2479151/Alcon will present new data on several of its latest contact lens, dry eye, and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted ab